Repligen Corporation (RGEN) NASDAQ
131.21
+4.12(+3.24%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
131.21
+4.12(+3.24%)
Currency In USD
| Previous Close | 127.09 |
| Open | 131.31 |
| Day High | 134.23 |
| Day Low | 130.29 |
| 52-Week High | 175.77 |
| 52-Week Low | 109.66 |
| Volume | 1.12M |
| Average Volume | 849,667 |
| Market Cap | 7.39B |
| PE | 152.57 |
| EPS | 0.86 |
| Moving Average 50 Days | 125.2 |
| Moving Average 200 Days | 138.33 |
| Change | 4.12 |
Repligen Corporation to Present at Upcoming March Conferences
GlobeNewswire Inc.
Mar 05, 2026 12:30 PM GMT
WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire Inc.
Feb 10, 2026 12:30 PM GMT
Webcast and Conference Call to Be Held Tuesday, February 24, 2026, at 8:30 a.m. ETWALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2025 financial re
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
GlobeNewswire Inc.
Jan 06, 2026 12:30 PM GMT
WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected Dr. Martin D. Madaus as Chair of the Board, eff